Community Healthcare Trust Inc
For the period ended Mar 31, 2024. Filed Apr 30, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed Apr 30, 2024
CHCT$15.27+2.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(Unaudited; Dollars in thousands)
| Three Months EndedMarch 31, | ||
|---|---|---|
| 2024 | 2023 | |
| OPERATING ACTIVITIES | ||
| Net income (loss) | $3,665 | $(6,922) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
| Depreciation and amortization | 10,262 | 9,018 |
| Other amortization | 217 | 265 |
| Stock-based compensation | 2,424 | 2,547 |
| Accelerated amortization of stock-based compensation | — | 11,799 |
| Straight-line rent receivable | (755) | (917) |
| Deferred income tax expense | — | 35 |
| Changes in operating assets and liabilities: | ||
| Other assets | (2,056) | (2,390) |
| Accounts payable and accrued liabilities | (1,079) | 133 |
| Other liabilities | (35) | (870) |
| Net cash provided by operating activities | 12,643 | 12,698 |
| INVESTING ACTIVITIES | ||
| Acquisitions of real estate | (34,297) | (23,895) |
| Funding of notes receivable | — | (1,295) |
| Proceeds from the repayment of notes receivable | 870 | 750 |
| Capital expenditures on existing real estate properties | (5,113) | (4,138) |
| Net cash used in investing activities | (38,540) | (28,578) |
| FINANCING ACTIVITIES | ||
| Net borrowings on revolving credit facility | 39,000 | 12,000 |
| Mortgage note repayments | (32) | (32) |
| Dividends paid | (12,684) | (11,646) |
| Proceeds from issuance of common stock | 540 | 8,215 |
| Taxes paid on behalf of employees and shares withheld upon shares vesting | (551) | — |
| Equity issuance costs | (63) | (100) |
| Net cash provided by financing activities | 26,210 | 8,437 |
| Increase (decrease) in cash, cash equivalents and restricted cash | 313 | (7,443) |
| Cash, cash equivalents and restricted cash, beginning of period | 4,633 | 12,068 |
| Cash, cash equivalents and restricted cash, end of period | $4,946 | $4,625 |
| Supplemental Cash Flow Information: | ||
| Interest paid (net of capitalized interest) | $4,790 | $3,866 |
| Invoices accrued for construction, tenant improvement and other capitalized costs | $4,591 | $3,274 |
| Reclassification of registration statement costs incurred in prior years to equity issuance costs | $72 | $52 |
| Increase (decrease) in fair value of cash flow hedges | $7,870 | $(4,973) |
| Income taxes paid | $26 | $60 |
| Capitalized interest | $28 | $192 |
| Net proceeds accrued for common stock issued in March with cash settlement in April | $— | $732 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.